ClinicalTrials.Veeva

Menu

Discordant Hormonal Status of Breast Cancer.

N

National Cancer Institute, Thailand

Status

Completed

Conditions

Malignant Neoplasm of Breast.

Study type

Observational

Funder types

Other

Identifiers

NCT01943032
EC 196/2010

Details and patient eligibility

About

The purpose of this study is to determine discordant hormonal status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Full description

Hormonal status between primary breast tumor and axillary lymph node were analyzed.

Enrollment

105 patients

Sex

Female

Ages

25 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

Exclusion criteria

  • Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.

Trial design

105 participants in 2 patient groups

Primary Breast Tumor
Description:
Immunohistochemical staining of paraffin embedded tissue blocks of primary breast tumor for estrogen and progesterone receptors was performed.
Axillary Lymph Nodes.
Description:
Immunohistochemical staining of paraffin embedded tissue blocks of axillary lymph nodes for estrogen and progesterone receptors was performed.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems